Report Overview

China Smart Inhalers market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of greater than XX% during the forecast period.

High level of air pollution and significant number of smokers in China is boosting the demand for inhalers in the country. The prevalence of asthma in China is approximately 4.2% which is approximately 45.7 million individuals 13.1 million of whom have airflow limitation. The Covid-19 pandemic is fatal and prevalent for the people having respiratory history boosting the demand for the inhalers in the country.



Market Drivers

Increase geriatric population along with respiratory disorders associated with them is fuelling the growth of smart inhaler market in China. Moreover, increasing incidence of respiratory diseases, the rise in air pollution, and growth in healthcare burden owing to higher cases of asthma and COPD. Better treatment options, ease of use, and technological advancements coupled with the increase in adherence rate of patients to smart inhalers are other major factors that drive this market.

Growing focus on the development of new devices in the medical sector is straight, elevating the demand for the smart inhalers market. These devices are beneficial for the physicians to track their patients inhale usage, which is additionally accelerating the growth rate of the market.